Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Massive liver transplant study aims to predict bleeding and save lives

NCT ID NCT06257407

Knowledge-focused Sponsor: Société Française d'Anesthésie et de Réanimation Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will follow 1,200 liver transplant patients in France to understand why some people bleed heavily during surgery while others don't. Researchers will use advanced methods like machine learning to build better prediction tools. The goal is to help doctors manage bleeding more effectively and reduce the need for blood transfusions.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this study could lead to better prediction tools for bleeding during liver transplants, helping doctors reduce unnecessary transfusions and improve patient safety.
What could go wrong
This is an observational study, not a treatment trial, so it won't directly change patient care. Results may not apply to all hospitals or patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,200 people

The number the study aims to enrol. It can still change while the study runs.

Started

Oct 2024

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Liver transplant patient

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patients aged 18 or over * Liver transplant patient Exclusion Criteria: * Multi-organ transplantation * Protected populations: under guardianship or curatorship * Patients not affiliated to a social security scheme

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Liver disease are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

liver disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Liver transplant; complications

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    16 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • CHU Claude Huriez

    RECRUITING

    Lille, France

  • CHU Estaing

    NOT_YET_RECRUITING

    Clermont, France

  • CHU Grenoble Alpes

    NOT_YET_RECRUITING

    Grenoble, France

  • CHU Haut Levêque

    NOT_YET_RECRUITING

    Pessac, France

  • CHU Hautepierre

    NOT_YET_RECRUITING

    Strasbourg, France

  • CHU La Timone

    NOT_YET_RECRUITING

    Marseille, France

  • CHU Pitié-Salpêtrière

    NOT_YET_RECRUITING

    Paris, France

  • CHU Pontchaillou

    NOT_YET_RECRUITING

    Rennes, France

  • CHU Toulouse Rangueil

    NOT_YET_RECRUITING

    Toulouse, France

  • CHU Tours

    NOT_YET_RECRUITING

    Tours, France

  • Chru Minjoz

    RECRUITING

    Besançon, France

  • Hôpital Beaujon

    NOT_YET_RECRUITING

    Clichy, France

  • Hôpital De L'Archet 2

    NOT_YET_RECRUITING

    Nice, France

  • Hôpital Paul Brousse

    RECRUITING

    Villejuif, France

  • Hôpital St Eloi

    NOT_YET_RECRUITING

    Montpellier, France

  • Hôpital de la Croix-Rousse

    RECRUITING

    Lyon, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.